Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Levi Garraway
Person

Levi Garraway

Tracked across 2 events · 16 articles · First seen Feb 16, 2026 · Last active Mar 09, 2026

Sentiment
25
Attention
4
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 50
Tech
Roche's Obinutuzumab/Obinutuzumabro Phase III Success
As Roche's Chief Medical Officer and Head of Global Product Development, Levi Garraway commented on the significance of the MAJESTY study results, highlighting Obinutuzumab/Obinutuzumabro's potential to help patients and address unmet medical needs.
Feb 16, 2026 · 7 articles
2 0
Business
Genentech's Giredestrant persevERA Study Fails
Levi Garraway, as the chief medical officer of Roche===Genentech, provided a statement acknowledging the persevERA study's results while expressing continued confidence in Giredestrant's broader potential.
Mar 09, 2026 · 9 articles
Relationships (1)
Roche===Genentech chief medical officer ↔ Levi Garraway Levi Garraway is the chief medical officer and head of Global Product Developmen
NEWSDESK
Track Levi Garraway live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.